This inventor holds 1 USPTO granted patent. Top assignee: Incyte Corporation. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations of Rory McAtee in Cancer Treatment
Introduction
Rory McAtee is an accomplished inventor based in Kennett Square, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target KRAS activity, which is crucial in cancer treatment.
Latest Patents
Rory McAtee holds a patent for "Tricyclic compounds as inhibitors of KRAS." This patent discloses compounds of Formula I, methods for using these compounds to inhibit KRAS activity, and pharmaceutical compositions that include such compounds. The compounds are particularly useful in treating, preventing, or ameliorating diseases or disorders associated with KRAS activity, such as cancer.
Career Highlights
Rory is currently employed at Incyte Corporation, where he continues to work on innovative solutions in the pharmaceutical industry. His research focuses on developing effective treatments for cancer, leveraging his expertise in chemical compounds.
Collaborations
Rory collaborates with Zhenwu Li, who is also a key contributor to their projects. Together, they work on advancing the understanding and treatment of diseases related to KRAS activity.
Conclusion
Rory McAtee's work exemplifies the impact of innovative research in the fight against cancer. His contributions through patents and collaboration with colleagues like Zhenwu Li highlight the importance of teamwork in scientific advancements.